Entry Point Capital, LLC Abbott Laboratories Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Entry Point Capital, LLC holds 3,522 shares of ABT stock, worth $459,585. This represents 0.18% of its overall portfolio holdings.
Number of Shares
3,522
Previous 2,116
66.45%
Holding current value
$459,585
Previous $241,000
65.15%
% of portfolio
0.18%
Previous 0.14%
Shares
4 transactions
Others Institutions Holding ABT
# of Institutions
3,290Shares Held
1.34BCall Options Held
9.72MPut Options Held
8.45M-
Vanguard Group Inc Valley Forge, PA169MShares$22 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$10 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.58 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.96 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...